![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2022
Li, Minglun; Fan, Yourong; Trapp, Christian; Schmidt-Hegemann, Nina Sophie; Ma, Jing; Buchner, Alexander; Lu, Shun; Xu, Bin; Stief, Christian; Wang, Xuanbin; Zhou, Cheng; Belka, Claus und Rogowski, Paul
(2022):
Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy.
In: Clinical and Translational Radiation Oncology, Bd. 39, 100571
He, Songjiang; Zhang, Shi; Yao, Yi; Xu, Bin; Niu, Zhili; Liao, Fuben; Wu, Jie; Song, Qibin; Li, Minglun und Liu, Zheming
(2022):
Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment.
In: Frontiers in Oncology, Bd. 12, 1064127
Shi, Run; Wang, Xin; Wu, Yang; Xu, Bin; Zhao, Tianyu; Trapp, Christian; Wang, Xuanbin; Unger, Kristian; Zhou, Cheng; Lu, Shun; Buchner, Alexander; Schulz, Gerald Bastian; Cao, Fengjun; Belka, Claus; Su, Chuan; Li, Minglun und Shu, Yongqian
(2022):
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
In: Theranostics, Bd. 12, Nr. 9: S. 4181-4199
2020
Han, Chao; Yu, Guopeng; Mao, Yuanshen; Song, Shangqing; Li, Long; Zhou, Lin; Wang, Zhong; Liu, Yushan; Li, Minglun und Xu, Bin
(2020):
LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
In: PLOS One 15(11), e0240801 [PDF, 1MB]
In: PLOS One 15(11), e0240801 [PDF, 1MB]